Patients Coming Off Slimming Injections Put On Weight Far More Rapidly Compared to People Using Diet and Exercise

A recent study indicates that patients who discontinue popular weight-loss injections like Mounjaro or Wegovy may regain shed pounds far faster than those who halt traditional diet and exercise programs.

Published data in a major health publication shows that while overweight people frequently drop substantial amounts of their body weight while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month after stopping.

"Individuals purchasing these treatments must be cognizant of the potential of rapid weight regain when the therapy is stopped," warns lead investigator Dr. Susan Jebb.

This pace of recovery means a reversion to original weight in about 18 months.

Analyzing Treatments

The analysis, which examined 37 of studies involving thousands of participants, compared the results of the injectable medications with older methods.

The team note that individuals who lose weight through lifestyle changes alone typically have a less rapid weight regain—perhaps 100 grams monthly—post-intervention.

Explaining the Rapid Rebound

Doctors suggest the way of the injections is key to understanding the heightened weight return.

These medications copy a body's own chemical called GLP-1, which helps regulate appetite.

"Long-term administration of GLP-1 concentrations several times higher than the body's typical production might result in the system to generate a reduced amount of its own natural GLP-1, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.

"Stopping of this hormone supplement leads to appetite is unsuppressed, making binge eating much more probable."

An Ongoing Disease?

Medical guidelines suggest the jabs for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications.

Professionals contend that, due to the high risk of relapse, the therapy is often life-long.

This perspective is echoed by pharmaceutical companies, who say that the results "highlight the long-term character of excess weight," similar to managing diseases like diabetes.

User Testimonies

Individuals who have stopped the jabs describe a sudden return of hunger.

"I experienced a trigger that goes on and I was suddenly ravenous," described a patient.

This difficulty is compounded if patients have not developed lasting lifestyle or habit modifications during treatment.

Widespread Use

Survey data indicate that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with interest being substantial.

• Use is higher among women than males.
• The 40s and 50s demographic shows the greatest level of interest.
• Many access the drugs through private prescriptions rather than the NHS.

In conclusion, researchers emphasize that while GLP-1 drugs are potent agents for weight loss, they are not a standalone cure and lasting health benefits likely depends on ongoing behavioural management.